ABP

Abpro Holdings, Inc Common Stock
ABP
Market cap $107M

2.07 USD

+0.58

38.93%

At close Dec 20, 4:00 PM EST

After hours

1.89

-0.18

8.70%

1 day

38.93%

5 days

20.35%

1 month

-39.30%

3 months

-44.20%

6 months

-44.20%

Year to date

-44.20%

1 year

-44.20%

5 years

-44.20%

10 years

-44.20%

About: Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms, The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with global pharmaceutical and research institutions.

Healthcare Biological Products, Except Diagnostic Substances

–

Funds holding %

of 6,809 funds

–

Analysts bullish %